The global nutraceutical CDMO market size is projected to expand with a CAGR of 5.6% during the assessment period. The market value is expected to increase from USD 35,730.8 million in 2024 to USD 61,655.3 million by 2034.
In 2023, the nutraceutical CDMO industry was valued at USD 33,466.0 million and is anticipated to exhibit a y-o-y growth of 6.8% in 2024. This robust growth is indicative of the escalating demand for nutraceutical products across the globe.
| Attributes | Key Insights |
|---|---|
| Base Market Value (2023) | USD 33,466.0 million |
| Estimated Market Size (2024) | USD 35,730.8 million |
| Projected Nutraceutical CDMO Market Value (2034) | USD 61,655.3 million |
| Value CAGR (2024 to 2034) | 5.6% |
In recent years, there has been a dramatic rise in the consumption of nutraceutical products due to increased health awareness and high interest in preventive healthcare. This, in turn, has put the nutraceutical CDMO industry into the limelight.
CDMOs provide end-to-end solutions encompassing research, development, manufacturing, testing, packaging, and logistics. This integrated approach streamlines the product development process, ensuring efficiency and reducing time-to-market.
The expertise of CDMOs is instrumental in formulating new and innovative nutraceutical products that meet evolving consumer demands. The focus on research and development within purpose-filled facilities allows CDMOs to stay at the forefront of industry advancements.
CDMOs are recognized for their ability to operate with agility and meet demanding timelines. Their streamlined processes and dedication to efficiency enable nutraceutical companies to bring products to market quickly, capturing opportunities in a rapidly evolving industry.
The global market for nutraceutical CDMOs recorded a CAGR of 4.6% from 2019 to 2023. Total market valuation reached around USD 33,466.0 million at the end of 2023. Over the assessment period, the target market is projected to exhibit a CAGR of 5.6%.
| Historical CAGR (2019 to 2023) | 4.6% |
|---|---|
| Forecast CAGR (2024 to 2034) | 5.6% |
The global nutraceutical market is witnessing steady growth, fueled by increasing health awareness and a growing preference for preventive healthcare. Consumers today are more proactive in managing their well-being, seeking dietary supplements and functional foods to address specific health concerns. This shift in consumer behavior is a key driver shaping the trajectory of the global nutraceutical CDMO industry.
Nutraceutical CDMOs have emerged as critical facilitators in this vibrant market, responding to consumer expectations by offering a spectrum of innovative and high-quality products. These organizations leverage their technical expertise and purpose-filled facilities to develop formulations that resonate with the health-conscious consumer demographic.
One notable aspect of the consumer-driven demand is the growing interest in personalized nutrition. Consumers are increasingly seeking tailored solutions that cater to their unique health needs. Nutraceutical CDMOs are responding to this trend by providing customization options, allowing companies to create products that align with specific consumer preferences.
The nutraceutical industry is subject to increased regulations, and compliance is paramount. Nutraceutical CDMOs, equipped with manufacturing expertise and a deep understanding of regulatory requirements, are becoming increasingly attractive partners for brands looking to outsource production. The trend toward outsourcing is expected to rise as companies seek to navigate complex regulatory landscapes efficiently.
A rising focus on reducing overall nutraceutical product development costs is expected to boost sales in the market. Subsequently, the growing demand for dietary supplement CDMO services will foster growth.
According to the Journal of Clinical Sleep Medicine, with about 30% of United States adults experiencing insomnia, there is a pronounced demand for effective sleep support solutions. Nutraceutical CDMOs can leverage their formulation expertise and manufacturing capabilities to develop innovative sleep aid products. This includes the production of sleep-inducing supplements, herbal formulations, and other solutions designed to improve sleep quality.
The growing rates of anxiety, depression, and heightened awareness of stress management present an opportunity for CDMOs to contribute to the development of mood and mental health support products. By incorporating scientifically-backed ingredients, CDMOs can formulate supplements that address specific mood-related concerns, providing consumers with effective and safe options for mental well-being.
Nutraceutical CDMOs have the flexibility to tailor formulations to specific health needs within the sleep, mood, and brain health segments. This customization can include the incorporation of herbal extracts, vitamins, minerals, and other bioactive compounds known for their therapeutic effects. The ability to create tailored solutions enhances the market appeal of these products.
The opportunity for nutraceutical CDMOs lies in addressing the burgeoning demand for sleep, mood, and brain health solutions. To benefit from this, CDMOs are focusing on providing tailored formulations, investing in research and development, and collaborating with brands at the forefront of these segments.
CDMOs are becoming key enablers in providing effective, high-quality nutraceuticals that cater to the unique health needs of consumers. As the sales of nutraceutical products continue to rise globally, so will the demand for nutraceutical contract development and manufacturing services.
One significant restriction affecting the nutraceutical CDMO market is the increasingly stringent regulatory landscape governing the production and marketing of nutraceutical products. Regulatory requirements, both at national and international levels, have become more complex, impacting the operations of CDMOs and influencing the overall market dynamics.
According to a report by the Global Organization for EPA and DHA Omega-3s (GOED), the regulatory environment for nutraceuticals has seen notable changes. For instance, in the United States, the Food and Drug Administration (FDA) has been focusing on implementing the Dietary Supplement Health and Education Act (DSHEA), ensuring the safety and quality of dietary supplements.
The European Food Safety Authority (EFSA) has been actively involved in evaluating health claims related to nutraceutical products, adding an additional layer of scrutiny. The need for compliance with stringent regulatory standards translates into increased compliance costs for nutraceutical CDMOs.
Investments in quality control, documentation, and adherence to Good Manufacturing Practices (GMP) become essential, impacting the overall operational expenses. The regulatory approval process for new formulations or ingredients can be time-consuming. Delays in obtaining approvals may hinder the speed-to-market advantage that CDMOs could otherwise offer to their clients, affecting the overall efficiency of product development.
The section highlights growth projections across prominent countries. China and Japan are predicted to register higher CAGRs of 7.4% and 3.4%, respectively, through 2034. This is due to the growing popularity of nutraceutical products in these nations. Similarly, the nutraceutical CDMO market in India and their emerging nations is expected to progress rapidly.
Market Growth Outlook by Key Countries
| Country | Value CAGR |
|---|---|
| United States | 1.8% |
| China | 7.4% |
| Japan | 3.4% |
| Germany | 1.7% |
| Spain | 2.8% |
The United States currently dominates the global nutraceutical CDMO industry with a share of around 32.6%. Over the forecast period, the United States nutraceutical CDMO market is expected to exhibit a CAGR of 1.8%.
The United has one of the leading markets for nutraceuticals globally. Rising health awareness and a growing aging population are creating a high demand for dietary supplements and functional foods in the United States. This, in turn, will boost the target market.
The presence of cutting-edge research facilities and a robust ecosystem for product development drives the demand for specialized services offered by nutraceutical CDMOs. The regulatory framework, including the Dietary Supplement Health and Education Act (DSHEA), provides a structured environment for the nutraceutical industry. This clarity contributes to the growth of the nutraceutical CDMO market by fostering compliance and ensuring product quality.
In 2023, China held a significant value share of 7.9% in the global nutraceutical CDMO market. Over the assessment period, demand for CDMO services in China is poised to grow with a CAGR of 7.4%.
China's rising middle class and increasing health and wellness awareness have fueled a growing demand for nutraceutical products. Similarly, the population's interest in preventive healthcare and dietary supplements has led to a thriving nutraceutical market. This is expected to drive the need for CDMOs to support the development and manufacturing of nutraceutical products.
The country’s government has shown support for the nutraceutical industry through favorable policies and regulations. The emphasis on health and wellness aligns with the government's broader public health initiatives, contributing to the growth of the nutraceutical CDMO market.
China is a key player in global manufacturing, and its nutraceutical CDMOs benefit from advanced manufacturing capabilities. The availability of cost-effective manufacturing services attracts both domestic and international companies looking for efficient production solutions.
Germany accounted for an 8.5% value share of the global market in 2023 and is expected to grow with a CAGR of 1.7% during the forecast period. This is due to the increasing consumption of functional foods and rising emphasis on research and innovation.
Germany is known for its commitment to quality and high manufacturing standards. Nutraceutical CDMOs in Germany often adhere to stringent quality control measures, attracting clients who prioritize product quality and safety.
The Germany market is characterized by sophisticated consumers who value premium and scientifically-backed nutraceutical products. CDMOs offering advanced formulation and production capabilities align well with the demands of this discerning market.
Germany has a strong emphasis on research and innovation in the healthcare sector. Nutraceutical CDMOs benefit from access to cutting-edge research and technology, contributing to their ability to offer innovative solutions to clients.
The section below highlights key segments' estimated market shares and CAGRs, including dosage form, services, and company size. This information can be vital for companies to frame their strategies accordingly.
Market Growth Outlook by Dosage Form
| Dosage Form | Value CAGR |
|---|---|
| Tablets & Capsules | 3.5% |
| Powder | 5.3% |
| Softgel | 6.9% |
| Liquid Formulations | 7.3% |
| Others (Gummies, Sprays, Sachets, Topical Forms) | 8.7% |
The tablets and capsules segment held a prominent market revenue share of 42.1% in 2023. Over the forecast period, the target segment is projected to advance with a CAGR of 3.5%. This is attributed to the rising popularity and consumption of nutraceutical tablets and capsules.
Tablets and capsules are popular dosage forms among consumers due to their convenience, ease of use, and familiarity. Many consumers find these solid oral dosage forms more convenient to incorporate into their daily routines than other formats like powders or liquid supplements.
Tablets and capsules are well-suited for high-volume manufacturing, making them cost-effective for both manufacturers and consumers. Hence, the target segment is expected to generate significant revenue in the global nutraceutical CDMO industry through 2034.
Market Growth Outlook by Services
| Services | Value CAGR |
|---|---|
| Product Formulation and Development | 5.3% |
| Manufacturing and Packaging | 4.7% |
| Research and Development | 6.1% |
| Analytical and Testing Services | 6.9% |
| Regulatory Support | 7.3% |
As per the latest analysis, demand remains high for nutraceutical manufacturing and packaging services in the market. The target segment held a market share of 33.1% in 2023. In the assessment period, it will likely grow with a CAGR of 4.7%.
Outsourcing manufacturing and packaging functions can be cost-effective for nutraceutical companies. CDMOs often have economies of scale, advanced equipment, and expertise in optimizing production processes, leading to cost savings for clients.
CDMOs specializing in manufacturing services often have extensive expertise in formulation development. This expertise allows them to create custom formulations that meet the specific requirements and preferences of nutraceutical brands, contributing to product differentiation and market competitiveness.
Market Growth Outlook by Key Company Size
| Company Size | Value CAGR |
|---|---|
| Small Companies | 5.8% |
| Mid-sized Companies | 4.7% |
| Large Companies | 7.3% |
The mid-sized companies segment accounted for a dominant industry share of nutraceutical CDMOs in 2023. Over the forecast period, it is poised to exhibit a CAGR of 4.7%.
Mid-sized CDMOs have the capability to offer personalized and customized services to their clients. Unlike larger CDMOs, they can provide a more hands-on and collaborative approach, working closely with clients to develop formulations, optimize processes, and meet specific requirements.
Mid-sized CDMOs are often characterized by a level of flexibility and agility that allows them to adapt quickly to changing market demands. As a result, the mid-sized companies category is expected to retain its market dominance through 2034.
Collaborations and acquisitions are common strategies employed by companies in the nutraceutical CDMO market to enhance their capabilities, expand their service offerings, and stay competitive in the dynamic landscape of advanced therapeutics. They are also integrating advanced technologies to improve their productivity.
Recent Developments in the Nutraceutical CDMO Market
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | USD 35,730.8 million |
| Projected Market Value (2034) | USD 61,655.3 million |
| Expected Growth Rate (2024 to 2034) | 5.6% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Middle East & Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Chile, China, Japan, South Korea, Germany, France, Spain, Italy, BENELUX, Nordic Countries, United Kingdom, BENELUX, Poland, Hungary, Romania, India, ASEAN Countries, Australia & New Zealand, Saudi Arabia, South Africa, Türkiye, Other African Union |
| Key Market Segments Covered | Dosage Form, Services, Company Size, and Region |
| Key Companies Profiled | Catalent; Lonza; Aenova Group; Akums Drugs and Pharmaceutical Ltd.; BASF SE; Sirio Pharma; Pharmavite LLC; Nature's Products, Inc.; PLT Health Solutions; Glanbia Nutritionals; Recipharm AB; B&D Nutritional Ingredients; NutraScience Labs; Vitakem Nutraceutical Inc.; Softigel (A division of Procaps Group); Iprona AG; Nutrilo GmbH; Atlantic Essential Products, Inc.; ProTec Nutra Ltd.; Nutraceuticals International Group |
| Report Coverage | Market Forecast, Competition Intelligence, Drivers, Restraints, Trends, Opportunities, Market Dynamics and Challenges, Strategic Growth Initiatives |
Table 1: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 2: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 3: Global Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 4: Global Market Size (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
Table 5: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 6: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 7: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 8: North America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 9: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 10: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 11: United States Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 12: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 13: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 14: Canada Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 15: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 16: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 17: Mexico Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 18: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 19: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 20: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 21: Latin America Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 22: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 23: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 24: Brazil Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 25: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 26: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 27: Chile Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 28: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 29: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 30: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 31: East Asia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 32: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 33: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 34: China Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 35: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 36: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 37: Japan Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 38: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 39: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 40: South Korea Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 41: South Asia & Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 42: South Asia & Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 43: South Asia & Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 44: South Asia & Pacific Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 45: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 46: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 47: India Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 48: ASEAN Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 49: ASEAN Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 50: ASEAN Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 51: Australia & New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 52: Australia & New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 53: Australia & New Zealand Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 54: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 55: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 56: Western Europe Respiratory Inhaler Devices Volume (Units) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 57: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 58: Western Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 59: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 60: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 61: Germany Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 62: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 63: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 64: Italy Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 65: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 66: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 67: France Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 68: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 69: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 70: United Kingdom Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 71: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 72: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 73: Spain Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 74: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 75: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 76: BENELUX Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 77: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 78: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 79: Nordic Countries Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 80: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 81: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 82: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 83: Eastern Europe Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 84: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 85: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 86: Russia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 87: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 88: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 89: Hungary Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 90: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 91: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 92: Poland Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 93: Middle East & Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
Table 94: Middle East & Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 95: Middle East & Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 96: Middle East & Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 97: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 98: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 99: Saudi Arabia Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 100: Turkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 101: Turkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 102: Turkiye Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 103: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 104: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 105: South Africa Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Table 106: Other African Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form
Table 107: Other African Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services
Table 108: Other African Union Market Value (US$ million) Analysis 2019 to 2023 and Forecast 2024 to 2034, By Company Size
Figure 1: Global Market Value Share By Dosage Form 2023 (A)
Figure 2: Global Market Value Share By Services 2023 (A)
Figure 3: Global Market Value Share By Company Size 2023 (A)
Figure 4: Global Market Value Share By Country 2023 (A)
Figure 5: Global Market Value Analysis (US$ Million), 2019 to 2023
Figure 6: Global Market Value Forecast (US$ Million), 2024 to 2034
Figure 7: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 8: Global Market Share Analysis (%), By Dosage Form, 2024 (E) & 2034 (F)
Figure 9: Global Market Y-o-Y Analysis (%), By Dosage Form, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis, By Dosage Form
Figure 11: Global Market Share Analysis (%), By Services, 2024 (E) & 2034 (F)
Figure 12: Global Market Y-o-Y Analysis (%), By Services, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis, By Services
Figure 14: Global Market Share Analysis (%), By Company Size, 2024 (E) & 2034 (F)
Figure 15: Global Market Y-o-Y Analysis (%), By Company Size, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis, By Company Size
Figure 17: Global Market Share Analysis (%), By Region, 2024 (E) & 2034 (F)
Figure 18: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 19: Global Market Attractiveness Analysis By Region, 2024 to 2034
Figure 20: North America Market Value Share By Dosage Form 2023 (A)
Figure 21: North America Market Value Share By Services 2023 (A)
Figure 22: North America Market Value Share By Company Size 2023 (A)
Figure 23: North America Market Value Share By Country 2023 (A)
Figure 24: North America Market Value (US$ Million) Analysis, 2019 to 2023
Figure 25: North America Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 27: North America Market Attractiveness Analysis By Services, 2024 to 2034
Figure 28: North America Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 30: Latin America Market Value Share By Dosage Form 2023 (A)
Figure 31: Latin America Market Value Share By Services 2023 (A)
Figure 32: Latin America Market Value Share By Company Size 2023 (A)
Figure 33: Latin America Market Value Share By Country 2023 (A)
Figure 34: Latin America Market Value (US$ Million) Analysis, 2019 to 2023
Figure 35: Latin America Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 37: Latin America Market Attractiveness Analysis By Services, 2024 to 2034
Figure 38: Latin America Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 40: East Asia Market Value Share By Dosage Form 2023 (A)
Figure 41: East Asia Market Value Share By Services 2023 (A)
Figure 42: East Asia Market Value Share By Company Size 2023 (A)
Figure 43: East Asia Market Value Share By Country 2023 (A)
Figure 44: East Asia Market Value (US$ Million) Analysis, 2019 to 2023
Figure 45: East Asia Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 46: East Asia Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 47: East Asia Market Attractiveness Analysis By Services, 2024 to 2034
Figure 48: East Asia Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 49: East Asia Market Attractiveness Analysis By Country, 2024 to 2034
Figure 50: South Asia & Pacific Market Value Share By Dosage Form 2023 (A)
Figure 51: South Asia & Pacific Market Value Share By Services 2023 (A)
Figure 52: South Asia & Pacific Market Value Share By Company Size 2023 (A)
Figure 53: South Asia & Pacific Market Value Share By Country 2023 (A)
Figure 54: South Asia & Pacific Market Value (US$ Million) Analysis, 2019 to 2023
Figure 55: South Asia & Pacific Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 56: South Asia & Pacific Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 57: South Asia & Pacific Market Attractiveness Analysis By Services, 2024 to 2034
Figure 58: South Asia & Pacific Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 59: South Asia & Pacific Market Attractiveness Analysis By Country, 2024 to 2034
Figure 60: Western Europe Market Value Share By Dosage Form 2023 (A)
Figure 61: Western Europe Market Value Share By Services 2023 (A)
Figure 62: Western Europe Market Value Share By Company Size 2023 (A)
Figure 63: Western Europe Market Value Share By Country 2023 (A)
Figure 64: Western Europe Market Value (US$ Million) Analysis, 2019 to 2023
Figure 65: Western Europe Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 66: Western Europe Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 67: Western Europe Market Attractiveness Analysis By Services, 2024 to 2034
Figure 68: Western Europe Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 69: Western Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 70: Eastern Europe Market Value Share By Dosage Form 2023 (A)
Figure 71: Eastern Europe Market Value Share By Services 2023 (A)
Figure 72: Eastern Europe Market Value Share By Company Size 2023 (A)
Figure 73: Eastern Europe Market Value Share By Country 2023 (A)
Figure 74: Eastern Europe Market Value (US$ Million) Analysis, 2019 to 2023
Figure 75: Eastern Europe Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 76: Eastern Europe Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 77: Eastern Europe Market Attractiveness Analysis By Services, 2024 to 2034
Figure 78: Eastern Europe Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 79: Eastern Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 80: Middle East & Africa Market Value Share By Dosage Form 2023 (A)
Figure 81: Middle East & Africa Market Value Share By Services 2023 (A)
Figure 82: Middle East & Africa Market Value Share By Company Size 2023 (A)
Figure 83: Middle East & Africa Market Value Share By Country 2023 (A)
Figure 84: Middle East & Africa Market Value (US$ Million) Analysis, 2019 to 2023
Figure 85: Middle East & Africa Market Forecast & Y-o-Y growth, 2024 to 2034
Figure 86: Middle East & Africa Market Attractiveness Analysis By Dosage Form, 2024 to 2034
Figure 87: Middle East & Africa Market Attractiveness Analysis By Services, 2024 to 2034
Figure 88: Middle East & Africa Market Attractiveness Analysis By Company Size, 2024 to 2034
Figure 89: Middle East & Africa Market Attractiveness Analysis By Country, 2024 to 2034
The global market value is estimated to total USD 35,730.8 million in 2024.
The global nutraceutical CDMO market size is projected to reach USD 61,655.3 million in 2034.
Demand for nutraceutical development and manufacturing services is set to rise at 5.6% CAGR.
The manufacturing and packaging segment held a dominant market share of 33.1% in 2023.
The global market increased at a 4.6% CAGR from 2019 to 2023.
The United States accounted for a 32.6% share of the global market in 2023.
China is poised to register a CAGR of 7.4% between 2024 and 2034.
Explore Similar Insights
Nutraceutical CDMO Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
